Evidence map›Paper›PMID 37153089›Full record

ArticleFrontiers in medicine2023

Exploring long COVID condition in Latin America: Its impact on patients' activities and associated healthcare use.

Adriana Angarita-Fonseca, Rodrigo Torres-Castro, Vicente Benavides-Cordoba, Santos Chero, Mauricio Morales-Satán, Bricia Hernández-López, Rafael Salazar-Pérez, Santiago Larrateguy, Diana C Sanchez-Ramirez

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 7 countries.

Adriana Angarita-FonsecaUniversité du Québec en Abitibi Témiscamingue, Rouyn-Noranda, QC, Canada.
Rodrigo Torres-CastroDepartment of Physical Therapy, University of Chile, Santiago, Chile.
Vicente Benavides-CordobaFacultad de Ciencias de la Salud, Pontificia Universidad Javeriana Cali, Cali, Colombia.
Santos CheroUniversidad Privada Norbert Wiener, Lima, Peru.
Mauricio Morales-SatánHospital General Docente de Calderón, Quito, Ecuador.
Bricia Hernández-LópezCentro de Enfermedades Respiratorias y Rehabilitación Pulmonar (CERRP), Pachuca, Mexico.
Rafael Salazar-PérezInstituto Profesional en Terapias y Humanidades, Puebla, Mexico.
Santiago LarrateguyUniversidad Adventista del Plata, Libertador San Martín, Argentina.
Diana C Sanchez-RamirezUniversity of Manitoba, Winnipeg, MB, Canada.
Hospital General Docente de CalderónInstituto Nacional de Enfermedades Respiratorias · MXInstituto Universitario de Tecnologia y Humanidades · MXPontificia Universidad Javeriana · COUniversidad Adventista del Plata · ARUniversidad Norbert Wiener · PEUniversité du Québec en Abitibi-Témiscamingue · CAUniversity of Chile · CLUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Studies exploring long COVID condition (LCC) in low- and middle-income countries are scarce. Further characterization of LCC patients experiencing activity limitations and their associated healthcare use is needed. This study aimed to describe LCC patients' characteristics, its impact on activities, and associated healthcare use in Latin America (LATAM). Participants: Individuals who (cared for someone or) had COVID-19 and could read, write, and comprehend Spanish and lived in a LATAM country were invited to complete a virtual survey. Sociodemographic characteristics, COVID-19 and LCC symptoms, activity limitations, and healthcare use. Results: Data from 2,466 people from 16 countries in LATAM were analyzed (females = 65.9%; mean age of 39.5 ± 53.3 years). 1,178 (48%) of the respondents had LCC symptoms (≥3 months). These were more likely to have COVID-19 earlier in the pandemic, were older, had no COVID vaccines, had more comorbidities, needed supplementary oxygen, and reported significantly more COVID-19 symptoms during the infectious period. 33% of the respondents visited a primary care provider, 13% went to the emergency department, 5% were hospitalized, 21% visited a specialist, and 32% consulted ≥1 therapist for LCC symptoms mainly extreme fatigue, sleep difficulties, headaches, muscle or joint pain, and shortness of breath with activity. The most consulted therapists were respiratory therapists (15%) and psychologists (14%), followed by physical therapists (13%), occupational therapists (3%), and speech pathologists (1%). One-third of LCC respondents decreased their regular activities (e.g., work, school) and 8% needed help with activities of daily living (ADLs). LCC respondents who reduced their activities reported more difficulty sleeping, chest pain with activity, depression, and problems with concentration, thinking, and memory, while those who needed help with ADLs were more likely to have difficulty walking, and shortness of breath at rest. Approximately 60% of respondents who experienced activity limitations sought a specialist and 50% consulted therapists. Conclusions and relevance: Results supported previous findings in terms of the LCC demographics, and provided insight into LCC impact on patients' activities and healthcare services used in LATAM. This information is valuable to inform service planning and resource allocation in alignment with the needs of this population.

Indexed as

activity limitationshealthcare useLatin Americalong COVIDlong COVID disability

Identifiers

PMID37153089
PMCPMC10157152
OpenAlexW4366596394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.